<VariationArchive VariationID="6110" VariationName="NM_004531.5(MOCS2):c.346_349del (p.Val116fs)" VariationType="Deletion" Accession="VCV000006110" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-15" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21149" VariationID="6110">
      <GeneList>
        <Gene Symbol="MOCS2" FullName="molybdenum cofactor synthesis 2" GeneID="4338" HGNC_ID="HGNC:7193" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="53095679" stop="53109757" display_start="53095679" display_stop="53109757" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="52393891" stop="52405597" display_start="52393891" display_stop="52405597" Strand="-" />
          </Location>
          <OMIM>603708</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004531.5(MOCS2):c.346_349del (p.Val116fs)</Name>
      <CanonicalSPDI>NC_000005.10:53101386:TGACTG:TG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="53101387" stop="53101390" display_start="53101387" display_stop="53101390" variantLength="4" positionVCF="53101386" referenceAlleleVCF="TTGAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="52397217" stop="52397220" display_start="52397217" display_stop="52397220" variantLength="4" positionVCF="52397216" referenceAlleleVCF="TTGAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>V116fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.53101389_53101392del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.53101389_53101392del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.52397219_52397222del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.52397219_52397222del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008435.2" sequenceAccession="NG_008435" sequenceVersion="2" change="g.13379_13382del">
            <Expression>NG_008435.2:g.13379_13382del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004531.5" sequenceAccession="NM_004531" sequenceVersion="5" change="c.346_349del" MANESelect="true">
            <Expression>NM_004531.5:c.346_349del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004522.1" sequenceAccession="NP_004522" sequenceVersion="1" change="p.Val116fs">
            <Expression>NP_004522.1:p.Val116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_176806.4" sequenceAccession="NM_176806" sequenceVersion="4" change="c.*266_*269del" MANEPlusClinical="true">
            <Expression>NM_176806.4:c.*266_*269del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA117942" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603708.0003" DB="OMIM" />
        <XRef Type="rs" ID="398122798" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004531.5(MOCS2):c.346_349del (p.Val116fs) AND Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B" Accession="RCV000006484" Version="6">
        <ClassifiedConditionList TraitSetID="1691">
          <ClassifiedCondition DB="MedGen" ID="C1854989">Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004531.5(MOCS2):c.346_349del (p.Val116fs) AND Combined molybdoflavoprotein enzyme deficiency" Accession="RCV000288995" Version="5">
        <ClassifiedConditionList TraitSetID="6473">
          <ClassifiedCondition DB="MedGen" ID="C0268119">Combined molybdoflavoprotein enzyme deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004531.5(MOCS2):c.346_349del (p.Val116fs) AND not provided" Accession="RCV003546452" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-12" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-12-06" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">10053004</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031595</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-12-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1691" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9039" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Molybdenum cofactor deficiency, complementation group B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B</ElementValue>
                <XRef ID="MONDO:0009644" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Molybdenum cofactor deficiency B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MOCODB</ElementValue>
                <XRef Type="MIM" ID="252160" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17387" />
                <XRef ID="17387" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Molybdenum cofactor deficiency (MoCD) represents a spectrum, with some individuals experiencing significant signs and symptoms in the neonatal period and early infancy (termed early-onset or severe MoCD) and others developing signs and symptoms in childhood or adulthood (termed late-onset or mild MoCD). Individuals with early-onset MoCD typically present in the first days of life with severe encephalopathy, including refractory seizures, opisthotonos, axial and appendicular hypotonia, feeding difficulties, and apnea. Head imaging may demonstrate loss of gray and white matter differentiation, gyral swelling, sulci injury (typically assessed by evaluating the depth of focal lesional injury within the sulci), diffusely elevated T2-weighted signal, and panlobar diffusion restriction throughout the forebrain and midbrain with relative sparring of the brain stem. Prognosis for early-onset MoCD is poor, with about 75% succumbing in infancy to secondary complications of their neurologic disability (i.e., pneumonia). Late-onset MoCD is typically characterized by milder symptoms, such as acute neurologic decompensation in the setting of infection. Episodes vary in nature but commonly consist of altered mental status, dystonia, choreoathetosis, ataxia, nystagmus, and fluctuating hypotonia and hypertonia. These features may improve after resolution of the inciting infection or progress in a gradual or stochastic manner over the lifetime. Brain imaging may be normal or may demonstrate T2-weighted hyperintense or cystic lesions in the globus pallidus, thinning of the corpus callosum, and cerebellar atrophy.</Attribute>
                <XRef ID="NBK575630" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34870926</ID>
                <ID Source="BookShelf">NBK575630</ID>
              </Citation>
              <XRef ID="308393" DB="Orphanet" />
              <XRef ID="833" DB="Orphanet" />
              <XRef ID="C1854989" DB="MedGen" />
              <XRef ID="MONDO:0009644" DB="MONDO" />
              <XRef Type="MIM" ID="252160" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2961" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined molybdoflavoprotein enzyme deficiency</ElementValue>
                <XRef ID="Combined+molybdoflavoprotein+enzyme+deficiency/8012" DB="Genetic Alliance" />
                <XRef ID="29692004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined deficiency of sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfite oxidase deficiency due to molybdenum cofactor deficiency</ElementValue>
                <XRef ID="MONDO:0020480" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Molybdenum cofactor deficiency</ElementValue>
                <XRef ID="HP:0003570" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MOCOD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3705" />
                <XRef ID="3705" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Molybdenum cofactor deficiency (MoCD) represents a spectrum, with some individuals experiencing significant signs and symptoms in the neonatal period and early infancy (termed early-onset or severe MoCD) and others developing signs and symptoms in childhood or adulthood (termed late-onset or mild MoCD). Individuals with early-onset MoCD typically present in the first days of life with severe encephalopathy, including refractory seizures, opisthotonos, axial and appendicular hypotonia, feeding difficulties, and apnea. Head imaging may demonstrate loss of gray and white matter differentiation, gyral swelling, sulci injury (typically assessed by evaluating the depth of focal lesional injury within the sulci), diffusely elevated T2-weighted signal, and panlobar diffusion restriction throughout the forebrain and midbrain with relative sparring of the brain stem. Prognosis for early-onset MoCD is poor, with about 75% succumbing in infancy to secondary complications of their neurologic disability (i.e., pneumonia). Late-onset MoCD is typically characterized by milder symptoms, such as acute neurologic decompensation in the setting of infection. Episodes vary in nature but commonly consist of altered mental status, dystonia, choreoathetosis, ataxia, nystagmus, and fluctuating hypotonia and hypertonia. These features may improve after resolution of the inciting infection or progress in a gradual or stochastic manner over the lifetime. Brain imaging may be normal or may demonstrate T2-weighted hyperintense or cystic lesions in the globus pallidus, thinning of the corpus callosum, and cerebellar atrophy.</Attribute>
                <XRef ID="NBK575630" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34870926</ID>
                <ID Source="BookShelf">NBK575630</ID>
              </Citation>
              <XRef ID="833" DB="Orphanet" />
              <XRef ID="99732" DB="Orphanet" />
              <XRef ID="C0268119" DB="MedGen" />
              <XRef ID="MONDO:0020480" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS252150" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003570" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7960374" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="3675663|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004274774" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21031595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10053004</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val116Asnfs*3) in the MOCS2B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MOCS2B are known to be pathogenic (PMID: 21031595). This variant is present in population databases (rs398122798, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with molybdenum cofactor deficiency (PMID: 10053004). This variant is also known as 533del4. ClinVar contains an entry for this variant (Variation ID: 6110). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MOCS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.52397217_52397220del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="26667" SubmissionDate="2017-02-17" DateLastUpdated="2024-07-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603708.0003_MOLYBDENUM COFACTOR DEFICIENCY, TYPE B" title="MOCS2, 4-BP DEL, NT533_MOLYBDENUM COFACTOR DEFICIENCY, TYPE B" />
        <ClinVarAccession Accession="SCV000026667" DateUpdated="2024-07-15" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Italian patient with molybdenum cofactor deficiency (MOCODB; 252160), Reiss et al. (1999) identified a homozygous 4-bp deletion, 533del4, in exon 5 of the MOCS2 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">10053004</ID>
              </Citation>
              <XRef DB="OMIM" ID="252160" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MOCS2" />
          </GeneList>
          <Name>MOCS2, 4-BP DEL, NT533</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT533</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603708.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MOLYBDENUM COFACTOR DEFICIENCY, TYPE B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="771386" SubmissionDate="2016-10-18" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="793893|Molybdenum Cofactor Deficiency" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000457865" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r4jv4v98/icsl_variant_classification_20161018.pdf</URL>
            <CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MOCS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_176806.3:c.*266_*269delGTCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Molybdenum Cofactor Deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ICSL_2016Q4</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26667" TraitType="Disease" MappingType="Name" MappingValue="MOLYBDENUM COFACTOR DEFICIENCY, TYPE B" MappingRef="Preferred">
        <MedGen CUI="C1854989" Name="Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="771386" TraitType="Finding" MappingType="Name" MappingValue="Molybdenum Cofactor Deficiency" MappingRef="Preferred">
        <MedGen CUI="C0268119" Name="Combined molybdoflavoprotein enzyme deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7960374" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

